Skip to NavigationSkip to content

Israel to present COVID booster-shot data to FDA

Published on 06/09/21 at 10:31am

This month Israel will present COVID booster-shot data to the FDA, which is weighing White House plans to begin a booster drive in the United States.

Sharon Alroy-Preis, Head of Public Health at Israel's Health Ministry, said the ministry had been asked by the FDA to brief its advisors.

A third booster shot of the Pfizer vaccine will be discussed, and potentially others.

Alroy-Preis told Israeli Channel 12 TV news: "We have been asked to come and present Israel's experience and our data so that we can truly help the whole world to learn.”

A week ago the country began offering a Pfizer COVID-19 booster to people as young as 12.

Israeli health officials said the drive has slowed a rise in severe illness caused by the now-dominant Delta variant.

Officials say this is due to effectiveness waning of the Pfizer vaccine after five to six months. It is said that a third shot restores the protection of the second shot.

In Israel, 2.6 million people out of a population of 9.3 million have received three doses of the Pfizer vaccine.

Lilly Subbotin

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches